• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1.人受体蛋白酪氨酸磷酸酶κ磷酸酶结构域1的晶体结构
Protein Sci. 2006 Jun;15(6):1500-5. doi: 10.1110/ps.062128706. Epub 2006 May 2.
2
The crystal structure of domain 1 of receptor protein-tyrosine phosphatase mu.受体蛋白酪氨酸磷酸酶μ第1结构域的晶体结构
J Biol Chem. 1997 Oct 31;272(44):27505-8. doi: 10.1074/jbc.272.44.27505.
3
Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.PTP-SL/PTPBR7催化结构域的晶体结构:对丝裂原活化蛋白激酶调节的影响
J Mol Biol. 2001 Aug 17;311(3):557-68. doi: 10.1006/jmbi.2001.4890.
4
Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.造血酪氨酸磷酸酶(HePTP)催化结构域的结构:一种活性位点结合有磷酸根的KIM磷酸酶的结构。
J Mol Biol. 2005 Nov 18;354(1):150-63. doi: 10.1016/j.jmb.2005.09.049. Epub 2005 Oct 3.
5
Crystal structure of the tandem phosphatase domains of RPTP LAR.受体型蛋白酪氨酸磷酸酶LAR串联磷酸酶结构域的晶体结构
Cell. 1999 May 14;97(4):449-57. doi: 10.1016/s0092-8674(00)80755-2.
6
Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.PTPN5、PTPRR和PTPN7的晶体结构及抑制剂鉴定:一类人类丝裂原活化蛋白激酶特异性蛋白酪氨酸磷酸酶
Biochem J. 2006 May 1;395(3):483-91. doi: 10.1042/BJ20051931.
7
Conservative tryptophan mutants of the protein tyrosine phosphatase YopH exhibit impaired WPD-loop function and crystallize with divanadate esters in their active sites.蛋白质酪氨酸磷酸酶YopH的保守色氨酸突变体表现出WPD环功能受损,且在其活性位点与二钒酸酯形成晶体。
Biochemistry. 2015 Oct 27;54(42):6490-500. doi: 10.1021/acs.biochem.5b00496. Epub 2015 Oct 14.
8
RPTPα phosphatase activity is allosterically regulated by the membrane-distal catalytic domain.RPTPα 磷酸酶活性通过膜远侧催化结构域进行变构调节。
J Biol Chem. 2020 Apr 10;295(15):4923-4936. doi: 10.1074/jbc.RA119.011808. Epub 2020 Mar 5.
9
Crystal structure of human protein tyrosine phosphatase 1B.人蛋白酪氨酸磷酸酶1B的晶体结构
Science. 1994 Mar 11;263(5152):1397-404.
10
The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.蛋白酪氨酸磷酸酶δ(PTPδ)的第二个催化结构域与PTPσ的第一个催化结构域结合并对其产生抑制作用。
Mol Cell Biol. 1998 May;18(5):2608-16. doi: 10.1128/MCB.18.5.2608.

引用本文的文献

1
Protein tyrosine phosphatase receptor type kappa (PTPRK) revisited: evolving insights into structure, function, and pathology.蛋白酪氨酸磷酸酶κ型受体(PTPRK)再探讨:对其结构、功能及病理学的新认识
J Transl Med. 2025 May 12;23(1):534. doi: 10.1186/s12967-025-06496-1.
2
The receptor PTPRU is a redox sensitive pseudophosphatase.受体 PTPRU 是一种氧化还原敏感的拟磷酸酶。
Nat Commun. 2020 Jun 26;11(1):3219. doi: 10.1038/s41467-020-17076-w.
3
Chemical activation of divergent protein tyrosine phosphatase domains with cyanine-based biarsenicals.基于花青基双砷试剂的化学激活具有差异的蛋白酪氨酸磷酸酶结构域。
Sci Rep. 2019 Nov 6;9(1):16148. doi: 10.1038/s41598-019-52002-1.
4
PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.PTPRK 表达在耐药性卵巢癌细胞系中下调,特别是在 ALDH1A1 阳性的 CSCs 样群体中。
Int J Mol Sci. 2019 Apr 25;20(8):2053. doi: 10.3390/ijms20082053.
5
The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion.同源受体 PTPRK 选择性去磷酸化多个连接调节剂,以促进细胞-细胞黏附。
Elife. 2019 Mar 29;8:e44597. doi: 10.7554/eLife.44597.
6
Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.经典蛋白酪氨酸磷酸酶变构抑制位点的合理设计。
Bioorg Med Chem. 2015 Jun 15;23(12):2828-38. doi: 10.1016/j.bmc.2015.03.027. Epub 2015 Mar 17.
7
The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells.赖氨酰氧化酶前肽与受体型蛋白酪氨酸磷酸酶 κ 相互作用,抑制肺癌细胞中β-连环蛋白的转录活性。
Mol Cell Biol. 2011 Aug;31(16):3286-97. doi: 10.1128/MCB.01426-10. Epub 2011 Jun 20.
8
Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn.蛋白酪氨酸磷酸酶受体T通过与细胞黏附分子和Fyn相互作用来调节突触形成。
EMBO J. 2009 Nov 18;28(22):3564-78. doi: 10.1038/emboj.2009.289. Epub 2009 Oct 8.

本文引用的文献

1
Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function.受体型蛋白酪氨酸磷酸酶κ调节表皮生长因子受体功能。
J Biol Chem. 2005 Dec 30;280(52):42694-700. doi: 10.1074/jbc.M507722200. Epub 2005 Oct 31.
2
Protein tyrosine phosphatase kappa and SHP-1 are involved in the regulation of cell-cell contacts at adherens junctions in the exocrine pancreas.蛋白酪氨酸磷酸酶κ和SHP-1参与外分泌胰腺中黏附连接的细胞间接触调节。
Gut. 2005 Oct;54(10):1445-55. doi: 10.1136/gut.2004.063164. Epub 2005 Jun 29.
3
Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.转化生长因子β(TGF-β)-Smad靶基因蛋白酪氨酸磷酸酶κ型受体是TGF-β功能所必需的。
Mol Cell Biol. 2005 Jun;25(11):4703-15. doi: 10.1128/MCB.25.11.4703-4715.2005.
4
Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45.受体蛋白酪氨酸磷酸酶CD45功能与调控的结构基础
J Exp Med. 2005 Feb 7;201(3):441-52. doi: 10.1084/jem.20041890. Epub 2005 Jan 31.
5
Protein tyrosine phosphatases in the human genome.人类基因组中的蛋白质酪氨酸磷酸酶。
Cell. 2004 Jun 11;117(6):699-711. doi: 10.1016/j.cell.2004.05.018.
6
Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.鉴定一种突变的受体样蛋白酪氨酸磷酸酶κ作为一种新型的、II类HLA限制性黑色素瘤抗原。
J Immunol. 2003 Jun 15;170(12):6363-70. doi: 10.4049/jimmunol.170.12.6363.
7
Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas.原发性中枢神经系统淋巴瘤中位于6q22 - 23的新型肿瘤抑制基因座。
Cancer Res. 2003 Feb 15;63(4):737-41.
8
Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.基于空间位阻的蛋白质酪氨酸磷酸酶选择性抑制剂的结构设计基础
Biochemistry. 2001 Dec 11;40(49):14812-20. doi: 10.1021/bi011389l.
9
Structural and evolutionary relationships among protein tyrosine phosphatase domains.蛋白质酪氨酸磷酸酶结构域之间的结构和进化关系。
Mol Cell Biol. 2001 Nov;21(21):7117-36. doi: 10.1128/MCB.21.21.7117-7136.2001.
10
Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.受体样蛋白酪氨酸磷酸酶α在细胞表面形成同源二聚体。
Mol Cell Biol. 2000 Aug;20(16):5917-29. doi: 10.1128/MCB.20.16.5917-5929.2000.

人受体蛋白酪氨酸磷酸酶κ磷酸酶结构域1的晶体结构

The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1.

作者信息

Eswaran Jeyanthy, Debreczeni Judit E, Longman Emma, Barr Alastair J, Knapp Stefan

机构信息

Structural Genomics Consortium, University of Oxford, Botnar Research Centre, Oxford OX3 7LD, United Kingdom.

出版信息

Protein Sci. 2006 Jun;15(6):1500-5. doi: 10.1110/ps.062128706. Epub 2006 May 2.

DOI:10.1110/ps.062128706
PMID:16672235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2242534/
Abstract

The receptor-type protein tyrosine phosphatases (RPTPs) are integral membrane proteins composed of extracellular adhesion molecule-like domains, a single transmembrane domain, and a cytoplasmic domain. The cytoplasmic domain consists of tandem PTP domains, of which the D1 domain is enzymatically active. RPTPkappa is a member of the R2A/IIb subfamily of RPTPs along with RPTPmu, RPTPrho, and RPTPlambda. Here, we have determined the crystal structure of catalytically active, monomeric D1 domain of RPTPkappa at 1.9 A. Structural comparison with other PTP family members indicates an overall classical PTP architecture of twisted mixed beta-sheets flanked by alpha-helices, in which the catalytically important WPD loop is in an unhindered open conformation. Though the residues forming the dimeric interface in the RPTPmu structure are all conserved, they are not involved in the protein-protein interaction in RPTPkappa. The N-terminal beta-strand, formed by betax association with betay, is conserved only in RPTPs but not in cytosolic PTPs, and this feature is conserved in the RPTPkappa structure forming a beta-strand. Analytical ultracentrifugation studies show that the presence of reducing agents and higher ionic strength are necessary to maintain RPTPkappa as a monomer. In this family the crystal structure of catalytically active RPTPmu D1 was solved as a dimer, but the dimerization was proposed to be a consequence of crystallization since the protein was monomeric in solution. In agreement, we show that RPTPkappa is monomeric in solution and crystal structure.

摘要

受体型蛋白酪氨酸磷酸酶(RPTPs)是整合膜蛋白,由细胞外黏附分子样结构域、单个跨膜结构域和一个胞质结构域组成。胞质结构域由串联的蛋白酪氨酸磷酸酶(PTP)结构域组成,其中D1结构域具有酶活性。RPTPκ是RPTPs的R2A/IIb亚家族成员之一,与RPTPμ、RPTPrho和RPTPlambda同属该亚家族。在此,我们测定了RPTPκ催化活性单体D1结构域在1.9埃分辨率下的晶体结构。与其他PTP家族成员的结构比较表明,其总体结构为经典的PTP结构,由扭曲的混合β折叠片层两侧为α螺旋组成,其中催化重要的WPD环处于无障碍的开放构象。尽管在RPTPμ结构中形成二聚体界面的残基都是保守的,但它们不参与RPTPκ中的蛋白质-蛋白质相互作用。由βx与βy缔合形成的N端β链仅在RPTPs中保守,而在胞质PTPs中不保守,并且这一特征在形成β链的RPTPκ结构中得以保留。分析型超速离心研究表明还原剂的存在和更高的离子强度对于维持RPTPκ为单体是必要的。在这个家族中,催化活性RPTPμ D1的晶体结构被解析为二聚体,但二聚化被认为是结晶的结果,因为该蛋白在溶液中是单体。与此一致,我们表明RPTPκ在溶液和晶体结构中均为单体。